A research engineer (spesialingeniør) position in molecular and cell biology is available in the research group targeted therapies and immunomodulation headed by Prof. Mouldy Sioud, Department of Cancer Immunology, Institute of Cancer Research, Oslo University Hospital-Radiumhospitalet.
The research group focuses on the development of new cancer therapeutics such as antibodies, antibody derivatives, and modified mRNA cancer vaccines using in vitro screening platforms and cell and molecular techniques. The position will provide a unique opportunity to pursue basic and translational research with the aim to identify novel targets and strategies for cancer immunotherapy.
Further information on the activity of the research group can be accessed at http://ous-research.no/sioud/. To date, the group has published 220 scientific papers, all of which are indexed in PubMed.
Oslo University Hospital is a workplace with great diversity. We believe this is crucial for solving our tasks in the best possible way. We want this diversity to be reflected among the applicants for our positions, and we encourage all qualified candidates, regardless of background, to apply!
The successful candidate will work closely with the group leader and other team members to design and conduct a range of in vitro and in vivo experiments, analyse experimental data, and contribute to scientific publications. The main aim is to identify cell-surface receptors involved in antibody binding to cancer cells and enhance the efficacy of mRNA-based cancer vaccines through mRNA modifications
The position is available for one year with the possibility for extension based on the candidate performance.
Only applications received through webcruiter will be considered and should include
Mouldi Sioud, Enhetsleder, mouldi.sioud@ous-research.no
Ullernchausseen 70
0310 Oslo
Arbeidsgiver: Oslo universitetssykehus HF
Referansenr.: 5195633177
Stillingsprosent: 100%
Contract
Startdato: 15.01.2027
Sluttdato: 14.01.2028
Søknadsfrist: 15.11.2026
Oslo University Hospital is a highly specialized hospital in charge of extensive regional and local hospital assignments. As Scandinavia’s largest hospital, we carry out more than 1.2 million patient treatments each year. The hospital has a nationwide responsibility for a number of national and multi-regional assignments, and has several national centers of competence. Oslo University Hospital is responsible for approximately 50 percent of all medical and health care research conducted at Norwegian hospitals, and is a significant role player within the education of a large variety of health care personnel.